Home > Healthcare > Drug Device Combination > Drug Filled Devices > Contraceptives Market

Contraceptives Market Share

Report ID: GMI430
Published Date: Sep 2024
Report Format: PDF

Download Free Sample

Contraceptives Market Share

Major players in the market are investing in research and development to introduce innovative products. Key developments include the launch of non-hormonal contraceptives, advancements in contraceptive delivery systems, and collaborations to enhance access to contraceptive products in underserved regions. For example, partnerships between pharmaceutical companies and non-governmental organizations are helping to expand the reach of affordable contraceptives in low-income countries.

Contraceptives Market Companies

Prominent players operating in the contraceptives industry include:

Afaxys, Inc.
Agile Therapeutics
Amneal Pharmaceuticals
Bayer AG
Church & Dwight Co., Inc.
Cooper Companies
Evofem Biosciences
HRA Pharma
Maxwellia Ltd
Mayer Laboratories, Inc.
Mithra Pharmaceuticals
Organon & Co.
Pfizer, Inc.
Reckitt Benckiser Group PLC
TherapeuticsMD, Inc.
Veru, Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global contraceptives industry was valued at USD 23 billion in 2023 and is expected to exhibit a CAGR of 6.3% from 2024 to 2032, attributed to increasing emphasis on prevention of sexually transmitted diseases, and growing awareness about new technologies for pregnancy prevention.

The devices segment generated the highest revenue of USD 16 billion in 2023 as their reliability and ease of use make them appealing to women seeking consistent and low-maintenance birth control.

North America contraceptives market accounted for USD 7.5 billion in 2023 and is anticipated to record a CAGR of 4% between 2024 to 2032, due to rising awareness of family planning and reproductive health, supported by government initiatives and healthcare policies.

Bayer AG, Church & Dwight Co., Inc., Cooper Companies, Evofem Biosciences, HRA Pharma, Maxwellia Ltd, Mayer Laboratories, Inc., and Mithra Pharmaceuticals among others.